当前位置:首页 - 行情中心 - 和邦生物(603077) - 财务分析

和邦生物

(603077)

  

流通市值:203.12亿  总市值:203.12亿
流通股本:88.31亿   总股本:88.31亿

和邦生物(603077)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润10.14亿元,每股收益0.12元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益2042436.42万元,未分配利润945120.56万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产2486096.00万元,负债443659.58万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入6,434,462,278.944,090,613,303.822,394,468,174.8413,038,947,986.8
营业总成本5,261,021,840.033,368,929,779.361,917,401,447.528,554,850,137.62
营业利润1,210,602,688.47729,549,281.19477,206,214.044,481,157,181.56
利润总额1,209,838,849.38728,835,852.35476,583,819.354,478,562,143.58
净利润1,014,075,433.12603,141,895.11381,460,623.93,810,238,934.75
其他综合收益-61,744.1814,074,680.68-11,232,306.6243,261,731.84
综合收益总额1,014,013,688.94617,216,575.79370,228,317.283,853,500,666.59
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计10,349,534,611.499,318,220,290.959,612,268,822.089,718,871,752.72
非流动资产合计14,511,425,379.8814,396,208,200.114,425,241,245.8314,383,755,427.76
资产总计24,860,959,991.3723,714,428,491.0524,037,510,067.9124,102,627,180.48
流动负债合计3,568,883,373.823,101,355,859.383,465,833,431.793,734,334,538.74
非流动负债合计867,712,444.52581,769,500.65401,834,679.75605,074,371.3
负债合计4,436,595,818.343,683,125,360.033,867,668,111.544,339,408,910.04
归属于母公司股东权益合计19,778,680,624.3419,393,137,463.8419,541,572,552.2219,118,356,709.62
股东权益合计20,424,364,173.0320,031,303,131.0220,169,841,956.3719,763,218,270.44
负债和股东权益合计24,860,959,991.3723,714,428,491.0524,037,510,067.9124,102,627,180.48
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计4,807,753,614.283,392,839,753.511,914,538,269.429,399,511,075.62
经营活动现金流出小计4,660,057,473.033,053,700,924.451,567,108,167.196,755,248,283.67
经营活动产生的现金流量净额147,696,141.25339,138,829.06347,430,102.232,644,262,791.95
投资活动现金流入小计121,557,333.913,936,341.652,535,519129,764,698.69
投资活动现金流出小计793,921,565.46441,815,973.21167,714,824.15937,007,033.01
投资活动产生的现金流量净额-672,364,231.55-437,879,631.56-165,179,305.15-807,242,334.32
筹资活动现金流入小计1,498,714,556.18743,711,568.99220,086,289.52,547,130,069.77
筹资活动现金流出小计1,797,914,114.491,577,100,184.77412,483,553.81,542,146,331.03
筹资活动产生的现金流量净额-299,199,558.31-833,388,615.78-192,397,264.31,004,983,738.74
汇率变动对现金及现金等价物的影响13,754,613.917,568,584.76-13,093,775.7521,856,130.86
现金及现金等价物净增加额-810,113,034.71-914,560,833.52-23,240,242.972,863,860,327.23
期末现金及现金等价物余额3,734,745,049.463,630,297,250.654,521,617,841.24,544,858,084.17
TOP↑